-
German stocks advanced to a three- week high amid optimism central banks will opt for further stimulus, and as companies including Deutsche Bank AG posted better than expected earnings.
-
Fresenius SE said first-quarter profit climbed 12 percent, boosted by the performance of two units that manage hospitals and sell intravenous therapies.
-
German stocks slid for a second day as European Central Bank President Mario Draghi said he sees risks to the region’s economic recovery and warned that monetary policy cannot compensate for lack of government action.
-
European stocks retreated, posting the biggest two-day slump in more than four months, as European Central Bank President Mario Draghi said that the economic recovery in the euro area remains subject to downside risks.
-
Affymax Inc. fell as much as 87 percent after the company and partner Takeda Pharmaceutical Co. voluntarily recalled an anemia treatment for kidney dialysis patients after reports of fatal reactions.
-
Affymax Inc. fell as much as 85 percent after the drugmaker and partner Takeda Pharmaceutical Co. voluntarily recalled an anemia treatment for kidney dialysis patients after reports of three fatal reactions.
-
Berkshire Hathaway Inc. is again giving stock pickers Todd Combs and Ted Weschler more money to invest after they beat the Standard & Poor’s 500 Index and left Warren Buffett “in the dust,” the billionaire chairman said.
-
German stocks advanced to a three- week high as Deutsche Boerse AG rallied after CME Group Inc. was said to approach the operator of the Frankfurt exchange to consider merger talks.
-
Democratic Representative Shelley Berkley of Nevada violated U.S. House rules “by improperly using her official position” to aid help her husband’s kidney dialysis business, the Ethics Committee said yesterday.
-
Affymax Inc. dropped to its lowest value ever after the company said it will fire three-quarters of its workforce and hire a bank to evaluate a possible sale or bankruptcy after the recall of its only drug.
Rate this Page